Go to Contents Go to Navigation

SK Bioscience wins US$31.3 mln deal to supply chickenpox vaccines to Latin America

All News 11:24 May 23, 2022

SEOUL, May 23 (Yonhap) -- South Korean vaccine maker SK Bioscience Co. said Monday it has secured a US$31.3 million deal from the Pan American Health Organization (PAHO) to supply chickenpox vaccines to Latin American countries.

SK Bioscience said it has recently delivered its first batch of shipments of SKY Varicella, the company's chickenpox vaccine introduced in 2018, to Central and South American countries through PAHO.

SK Bioscience said it won the deal from PAHO in February.

PAHO is an international public health agency working to improve the health standards of the people of the Americas. It is part of the United Nations system, serving as the regional office for the Americas of the World Health Organization (WHO).

In 2019, SK Bioscience's SKY Varicella received its prequalification (PQ) from the WHO, a requirement to become a supplier to PAHO and other international organizations.

This photo provided by SK Bioscience Co. shows the company's chickenpox vaccine SKY Varicella. (PHOTO NOT FOR SALE) (Yonhap)


Send Feedback
How can we improve?
Thanks for your feedback!